- The key vendors in the Global Type 2 Diabetes Therapeutics Market 2015-2019 are AstraZeneca plc, Novartis AG and Novo Nordisk A/S.
London, 02 December 2014: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global Type 2 Diabetes Therapeutics Market 2015-2019. One major trend upcoming in this market is the increasing focus on emerging markets. As a result of an increase in the diabetic population, and increased accessibility to disease monitoring and disease management devices, key vendors have begun to focus on emerging markets such as China. The overall market is expected to witness a CAGR of 7.15 percent during the forecast period of 2014-2019.
“Key players in the Global Diabetes Therapeutics market are increasingly extending their support to academic institutions to facilitate the R&D of innovative products for the treatment of diabetes,” says Faisal Ghaus, Vice President of TechNavio Research.
“Collaborations in the market enable the amalgamation of research expertise of educational institutions with the marketing intelligence of pharma companies, as well as providing funds to conduct trials.”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
